Howard Robin, President & CEO, Director at Nektar Therapeutics, holds 848.77K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Howard Robin Sold $14,881 shares of Nektar Therapeutics on Aug 20, 2024 for an estimated value of 19.05K.
What is the percentage of profitable transactions made by Howard Robin?
The percentage of profitable transactions made by Howard Robin is 21%.
What is the average return per transaction made by Howard Robin?
The average return per transaction made by Howard Robin is -90.10%.
What stocks does Howard Robin hold?
Howard Robin holds: NKTR stocks.
What was Howard Robin’s latest transaction?
Howard Robin latest transaction was an Informative Sell of $19.05K.
What was Howard Robin's most profitable transaction?
Howard Robin’s most profitable transaction was an Informative Sell of NKTR stock on November 18, 2022. The return on the trade was 86.20%.
What is Howard Robin's role in Nektar Therapeutics?
Howard Robin's role in Nektar Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.